Contact
Please use this form to send email to PR contact of this press release:
Health Canada Issues Notice of Compliance for REDESCA, Valeo Pharma Continues to Execute on In-Licensing Strategy
TO:
Fredrick William
Market Equities Research Group
+1 866-620-9945